MicroRNA-101 Inhibits Cell Proliferation, Invasion, and Promotes Apoptosis by Regulating Cyclooxygenase-2 in Hela Cervical Carcinoma Cells

  • Huang, Fei (Department of Pathology, Basic Medical Sciences, Xinjiang Medical University) ;
  • Lin, Chen (Department of Pathology, Basic Medical Sciences, Xinjiang Medical University) ;
  • Shi, Yong-Hua (Department of Pathology, Basic Medical Sciences, Xinjiang Medical University) ;
  • Kuerban, Gulinar (Department of Pathology, Basic Medical Sciences, Xinjiang Medical University)
  • Published : 2013.10.30


Aim: Although aberrant miRNA expression has been documented, altered miR-101 expression in cervical cancer and its carcinogenic effects and mechanisms remain unexplored. The aim of our study was to investigate the role of miR-101 alteration in cervical carcinogenesis. Methods: Expression of miR-101 was examined by quantitative real-time reverse transcriptase PCR (qRT-PCR) in Hela cells. After modulating miR-101 expression using miR-101 mimics, cell growth, apoptosis and proliferation, and migration were tested separately by MTT or flow cytometry and cell wound healing assay and protein expression was detected by qRT-PCR. The expression of COX-2 in Hela cell was also examined by immunohistochemical staining and the correlation with miR-101 expression was analysed. Results: The miR-101 demonstrated significantly low expression in Hela cell. When we transfected miR-101 mimics into Hela cells, the modulation of miR-101 expression remarkably influenced cell proliferation, cycling and apoptosis: 1) The expression of microRNA-101 tended to increase after transfection; 2) Overexpression of miR-101 was able to promote cell apoptosis, the apoptosis rate being markedly higher (97.6%) than that seen pre-transfection (12.2%) (P<0.05); 3) The miR-101 negatively regulates cell migration and invasion, scratch results being lower ($42.7um{\pm}2um$) than that observed pre-transfection ($181.4um{\pm}2um$); 4) miRNA-101 inhibits the proliferation of Hela cells as well as the level of COX-2 protein, which was negatively correlated with miR-101 expression. Conclusions: Overexpression of miR-101 has obvious inhibitory effects on cell proliferation, migration and invasion. Thus reduced miR-101 expression could participate in the development of cervical cancer at least partly through loss of inhibition of target gene COX-2, which probably occurs in a relative late phase of carcinogenesis. Our data suggest an important role of miR-101 in the molecular etiology of cancer and indicate potential application of miR-101 in cancer therapy.


MicroRNA;cervical cancer;proliferation;transfection;COX-2


  1. Agra Andrieu N, Motino O, Mayoral R, et al (2012). Cyclooxygenase-2 is a target of microRNA-16 in human hepatoma cells. PLoS One, 7, e50935.
  2. Arbyn M, Castellsague X, de Sanjose S, et al (2011). Worldwide burden of cervical cancer in 2008. Ann Oncol, 22, 2675-86.
  3. Buechner J, Tomte E, Haug BH, et al (2011). Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma. Br J Cancer, 105, 296-303.
  4. Bumgarner SL, Dowell RD, Grisafi P, Gifford DK, Fink GR (2009). Toggle involving cis-interfering noncoding RNAs controls variegated gene expreassion in yeast. Proc Natl Acad SciUSA, 106, 18321-6.
  5. Chen DL, Wang DS, Wu WJ (2013). Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer. Carcinogenesis, 34, 803-11.
  6. Chen K, Fan W, Wang X (2012). MicroRNA-101 mediates the suppressive effect of laminar shear stress on mTOR expression in vascularendothelial cells. Biochem Biophys Res Commun, 427, 138-42.
  7. Ding L, Hu XM, Wu H (2013). Combined transfection of Bcl-2 siRNA and miR-15a oligonucleotides enhanced methotrexate-induced apoptosis in Raji cells. Cancer Biol Med, 10, 16-21.
  8. Cho HM, Jeon HS , Lee SY (2011). microRNA-101 inhibits lung cancer invasion through the regulation of enhancer of zeste homolog 2. Exp Ther Med, 2, 963-7.
  9. Cui J, Eldredge JB, Xu Y, Puett D (2011). MicroRNA expression and regulation in human ovarian carcinoma cells by luteinizing hormone. PLoS One, 6, 21730.
  10. Dixon DA, Blanco FF, Bruno A, Patrignani P (2013) Mechanistic aspects of COX-2 expression in colorectal neoplasia. Recent Results Cancer Res, 191, 7-37.
  11. Dykxhoorn DM (2010). MicroRNAs and metastasis: little RNAs go a long way. Cancer Res, 70 , 6401-6.
  12. Forman D, de Martel C, Lacey CJ, et al (2012). Global burden of human papillomavirus and related diseases. Vaccine, 5, F12-23.
  13. Godlewski J, Nowicki MO, Bronisz A, et al (2008). Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and selfrenewal. Cancer Res, 68 , 9125-30.
  14. Hao Y, Gu X , Zhao Y, et al (2011) .Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo. Cancer Prev Res (Phila), 4, 1073-83.
  15. He XP, Shao Y , Li XL, et al (2012). Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth. FEBS J, 279, 4201-12.
  16. Hsia TC, Tu CY, Chen YJ, et al (2013). Lapatinib-mediated cyclooxygenase-2 expression via epidermal growth factor receptor/HuR interaction enhances the aggressiveness of triple-negative breast cancer cells. Mol Pharmacol, 83, 857-69.
  17. Kefas B, Godlewski J, Comeau L, et al (2008). microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res, 68, 3566-72.
  18. Hu Z, Lin Y , Chen H (2013). MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-Met. Biochem Biophys Res Commun, 435, 82-7.
  19. Ivey KN and Srivastava D (2010). MicroRNAs as regulators of differentiation and cell fate decisions. Cell Stem Cell, 7, 36-41.
  20. Jiang J, Gusev Y, Aderca I (2008). Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res, 14, 419-27.
  21. Kim YK, Heo I and Kim VN (2010). Modifications of small RNAs and their associated proteins. Cell, 143, 703-9.
  22. Krol J, Loedige I and Filipowicz W (2010). The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet, 11, 597-610.
  23. Kumar S, Keerthana R, Pazhanimuthu A, Perumal P (2013). Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients. Indian J Biochem Biophys, 50, 210-4.
  24. Lalaisuzuke, Peng YH, Zhou K, et al (2006). The analysis of pathogenetic tendency of cervical cancer in various ethnic women in Xinjiang. J Xinjiang Medl Univ, 7, 569-71.
  25. Li Y, Tan SQ, Ma QH (2013). CYP1B1 C4326G polymorphism and susceptibility to cervical cancer in Chinese Han women. Tumour Biol.
  26. MenterDG, Schilsky RL, DuBois RN (2010). Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward. Clin Cancer Res, 5, 1384-90.
  27. Semaan A, Qazi AM, Seward S, et al (2011). MicroRNA-101 inhibits growth of epithelial ovarian cancer by relieving chromatin-mediated transcriptional repression of p21 (waf1/cip1). Pharm Res, 28 , 3079-90.
  28. Palumbo S, Miracco C, Pirtoli L, Comincini S (2013). Emerging roles of microRNA in modulating cell-death processes in malignant glioma. J Cell Physiol, 10.1002/jcp.24446.
  29. Peralta-Zaragoza O, Deas J, Gomez-Ceron C (2013). HPV-Based screening, triage, treatment, and followup strategies in the management of cervical intraepithelial neoplasia. Obstet Gynecol Int, 2013, 912780.
  30. Schwarzenbacher D, Balic M, Pichler M (2013). The role of microRNAs in breast cancer stem cells. Int J Mol Sci, 14, 14712-23.
  31. Shen XH, Liu SH (2013). Human papillomavirus genotypes associated with mucopurulent cervicitis and cervical cancer in Hangzhou, China. Asian Pac J Cancer Prev, 14, 3603-6.
  32. Strillacci A, Griffoni C, Sansone P, et al (2009). MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. Exp Cell Res, 15, 1439-47.
  33. Su H, Yang JR, Xu T (2009). MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res, 69, 1135-42.
  34. Tanaka T, Haneda S, Imakawa K, Sakai S, Nagaoka K. (2009). A microRNA, miR-101a, controls mammary gland development by regulating cyclooxygenase-2 expression. Differentiation, 77, 181-7.
  35. Wang HJ, Ruan HJ, He XJ, et al (2010). MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur J Cancer, 46, 2295-303.
  36. Yu Z, Baserga R, Chen L (2010). microRNA, cell cycle, and human breast cancer. Am J Pathol, 176 , 1058-64.
  37. Wang D, Dubois RN (2010). The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene, 29, 781-8.
  38. Wu SY, Lin KC, Chiou JF (2013). MicroRNA-17-5p post-transcriptionally regulates p21 expression in irradiated betel quid chewing-related oral squamous cell carcinoma cells. Strahlenther Onkol, 189, 675-83.
  39. Xie H, Zhao Y, Caramuta S, Larsson C, Lui WO (2012). miR-205 expression promotes cell proliferation and migration of human cervical cancer cells. PLoS One, 7, e46990.
  40. Zhang JY, Yang J, Song NH (2013). Relationship between aberrant expression of miRNAs and prostate cancer. Zhonghua Nan Ke Xue, 19, 657-61.
  41. Zhang Y, Guo X, Xiong L (2012). MicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of humanhepatocellular carcinoma. FEBS Lett, 586, 4362-70.

Cited by

  1. miR-186 Regulates Glycolysis through Glut1 During the Formation of Cancer-associated Fibroblasts vol.15, pp.10, 2014,
  2. miR-200a Inhibits Tumor Proliferation by Targeting AP-2γ in Neuroblastoma Cells vol.15, pp.11, 2014,
  3. MiRNA-15a Mediates Cell Cycle Arrest and Potentiates Apoptosis in Breast Cancer Cells by Targeting Synuclein-γ vol.15, pp.16, 2014,
  4. The -765G>C Polymorphism in the Cyclooxygenase-2 Gene and Digestive System Cancer: a Meta-analysis vol.15, pp.19, 2014,
  5. Oncogenic and tumor suppressive roles of microRNAs in apoptosis and autophagy vol.19, pp.8, 2014,
  6. Effect of microRNA-101 on proliferation and apoptosis of human osteosarcoma cells by targeting mTOR vol.34, pp.6, 2014,
  7. Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies vol.128, pp.3, 2015,
  8. MiR-323-5p acts as a Tumor Suppressor by Targeting the Insulin-like Growth Factor 1 Receptor in Human Glioma Cells vol.15, pp.23, 2015,
  9. A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer vol.22, pp.2, 2015,
  10. Interleukin-1β-mediated suppression of microRNA-101 and upregulation of enhancer of zeste homolog 2 is involved in particle-induced lung cancer vol.32, pp.1, 2015,
  11. Paclitaxel combined with harmine inhibits the migration and invasion of gastric cancer cells through downregulation of cyclooxygenase‑2 expression pp.1792-1082, 2015,
  12. Deregulated miRNAs in human cervical cancer: functional importance and potential clinical use vol.13, pp.8, 2017,
  13. CASC2c as an unfavorable prognosis factor interacts with miR-101 to mediate astrocytoma tumorigenesis vol.8, pp.3, 2017,
  14. gga-miR-101-3p Plays a Key Role in Mycoplasma gallisepticum (HS Strain) Infection of Chicken vol.16, pp.12, 2015,
  15. Heat shock factor 2 is associated with the occurrence of lung cancer by enhancing the expression of heat shock proteins vol.12, pp.6, 2016,
  16. Protective effects of microRNA-431 against cerebral ischemia-reperfusion injury in rats by targeting the Rho/Rho-kinase signaling pathway vol.233, pp.8, 2018,